Camilla

Four Seasons Honours World Kindness Day with a Global Celebration of Art, Community and Acts of Love

Retrieved on: 
Wednesday, November 8, 2023
Painting, Spectrum, Lilly, Camilla, Four Seasons Resort Hualalai, Social media, Flower, Four Seasons, ESG, ICAF, Lickety Split, Heart, Wildfire, Life, Walt Disney World, History, Food, International Child Art Foundation, Walt Disney, Ko Olina Resort, Creativity, World Kindness Day, Season, Immersion, United States Capitol, True and the Rainbow Kingdom, Nemours Children's Hospital, Golden Rule, Student, Partnership, Hurricane Lidia, Architect of the Capitol, Love, National Mall, Four Seasons Hotels and Resorts, Universidad, Ceramic, Movement, Patient, Visual arts, Empathy, Hospital, Interior design, Nightclub, Entertainment, Tourism, Pharmaceutical industry, Hotel, Resort

TORONTO, Nov. 8, 2023 /PRNewswire/ -- This World Kindness Day, Four Seasons is embracing its legacy of empathy and personalized service to inspire others to lead with genuine heart. Grounded in the core belief that kindness creates a meaningful sense of belonging, Four Seasons hotels and resorts are uniting in a celebration of kindness on November 13 and beyond through community and artistic collaborations and volunteerism.

Key Points: 
  • "Our World Kindness Day celebration is a natural extension of how we seek to leave a positive, enduring impact on our communities.
  • With a shared passion for the power of kindness, Four Seasons is collaborating with Lilly Singh to inspire kindness through her light-hearted warmth and humour.
  • To kick off the celebration, Lilly joined Four Seasons for an event on November 7 in advance of World Kindness Day at Four Seasons Hotel Los Angeles at Beverly Hills .
  • Click here to see a full list of Four Seasons hotels and resorts around the world that are creating kindness in their communities.

Scania appoints Camilla Dewoon as Head of Communications and Sustainability and member of Scania Executive Board

Retrieved on: 
Thursday, June 9, 2022
Marketing, Union of Sales and Marketing Professionals, CEO, Minister charged with the administration of The Crown Corporations Public Review and Accountability Act (Manitoba), Ecosystem, Method, Industry, Board of directors, Communication, Camilla, Commercial Operating System (COS), Management, Science, Economics

SDERTLJE,Sweden, June 9, 2022 /PRNewswire/ --Camilla Dewoon, currently Chief Communications Officer at Scania, has been appointed Executive Vice President and Head of Communicationsand Sustainability.

Key Points: 
  • SDERTLJE,Sweden, June 9, 2022 /PRNewswire/ --Camilla Dewoon, currently Chief Communications Officer at Scania, has been appointed Executive Vice President and Head of Communicationsand Sustainability.
  • As from 9 June 2022, she will be part of Scania's Executive Board and report to Christian Levin, President and CEO.
  • "With sustainability being at the core of Scania's business strategy, communication is a tool to deliver on it.
  • Prior to being Chief Communications Officer at Scania, she was a senior consultant outside the company.

F2G appoints Camilla Soenderby to Board of Directors

Retrieved on: 
Wednesday, September 15, 2021
Goodyear F2G Corsair, European Medicines Agency, Board of directors, DHODH, NDA, QIDP, Mycosis, Antifungal, R, Board, CEO, Patient, Aspergillosis, SVP, McKinsey & Company, Growth, Takeda, Schering-Plough, Partnership, Infection, Camilla, Acquisition, Chronic pulmonary aspergillosis, Orotomide, Coccidioidomycosis, AbbVie, Pharmaceutical industry, Management

MANCHESTER, England, PRINCETON, N.J.and VIENNA, Sept. 15, 2021 /PRNewswire/ -- F2G Ltd, a clinical-stage biopharmaceutical company focused on rare life-threatening fungal diseases with a high unmet medical need, today announces the appointment of Camilla Soenderby as a Non-Executive Director to its Board of Directors with immediate effect.

Key Points: 
  • MANCHESTER, England, PRINCETON, N.J.and VIENNA, Sept. 15, 2021 /PRNewswire/ -- F2G Ltd, a clinical-stage biopharmaceutical company focused on rare life-threatening fungal diseases with a high unmet medical need, today announces the appointment of Camilla Soenderby as a Non-Executive Director to its Board of Directors with immediate effect.
  • Patrick Vink, Chairman of F2G Ltd, said: "On behalf of the whole board I am very pleased to welcome Camilla to F2G.
  • Camilla began her career as a management consultant at McKinsey & Co. focused on the biopharmaceutical and medical devices industries.
  • F2G is a world-leading biotech company focused on the discovery and development of novel therapies to treat life-threatening invasive fungal infections.

F2G appoints Camilla Soenderby to Board of Directors

Retrieved on: 
Wednesday, September 15, 2021
Goodyear F2G Corsair, European Medicines Agency, Board of directors, DHODH, NDA, QIDP, Mycosis, Antifungal, R, Board, CEO, Patient, Aspergillosis, SVP, McKinsey & Company, Growth, Takeda, Schering-Plough, Partnership, Infection, Camilla, Acquisition, Chronic pulmonary aspergillosis, Orotomide, Coccidioidomycosis, AbbVie, Pharmaceutical industry, Management

MANCHESTER, England, PRINCETON, N.J. and VIENNA, Sept. 15, 2021 /PRNewswire/ -- F2G Ltd, a clinical-stage biopharmaceutical company focused on rare life-threatening fungal diseases with a high unmet medical need, today announces the appointment of Camilla Soenderby as a Non-Executive Director to its Board of Directors with immediate effect.   

Key Points: 
  • MANCHESTER, England, PRINCETON, N.J.and VIENNA, Sept. 15, 2021 /PRNewswire/ -- F2G Ltd, a clinical-stage biopharmaceutical company focused on rare life-threatening fungal diseases with a high unmet medical need, today announces the appointment of Camilla Soenderby as a Non-Executive Director to its Board of Directors with immediate effect.
  • Patrick Vink, Chairman of F2G Ltd, said: "On behalf of the whole board I am very pleased to welcome Camilla to F2G.
  • Camilla began her career as a management consultant at McKinsey & Co. focused on the biopharmaceutical and medical devices industries.
  • F2G is a world-leading biotech company focused on the discovery and development of novel therapies to treat life-threatening invasive fungal infections.

Class Action Commenced Against Camilla Care

Retrieved on: 
Thursday, September 10, 2020
Health, Articles, COVID-19 pandemic in Canada, Camilla Care Community, Caregiving, Sienna Senior Living, Elderly care, Camilla, Duchess of Cornwall, Camilla, Nursing home, Long-term care

Toronto, ON, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Thomson Rogers has issued a class action proceeding claiming $25 million on behalf of residents of Camilla Care Community and their families.

Key Points: 
  • Toronto, ON, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Thomson Rogers has issued a class action proceeding claiming $25 million on behalf of residents of Camilla Care Community and their families.
  • Camilla Care Community ("Camilla Care") is a long-term care home owned by Sienna Senior Living Inc ., located in Mississauga, Ontario.
  • Mehri contracted COVID-19 while residing in a shared bedroom with three other residents at Camilla Care and died on May 28, 2020.
  • Camilla Care is also one of many long-term care homes in Ontario that requires four residents to share a single bedroom.